NFKB1 and neoplasm: p55PIK and KIT protein expression, and NF-κB p65 (Ser536) phosphorylation were also strongly increased, even in IMA-resistance tumor samples from GIST patients with secondary mutations (No. 3 and 5, marked with #) (Figure 6C).